Expanded human CD8+CD45RClowFoxp3+ Tregs secreting IFNγ, IL-10, IL-34 and TGFβinhibit human transplant rejection - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Poster De Conférence Année : 2017

Expanded human CD8+CD45RClowFoxp3+ Tregs secreting IFNγ, IL-10, IL-34 and TGFβinhibit human transplant rejection

Résumé

Tregs play a critical role in the control of immune responses and tolerance induction; however our understanding of CD8+ Tregs is limited while they are particularly promising for therapeutic application. We previously reported that CD8+CD45RC[low] Tregs use IFNγ and IL-34 to suppress donor responses in a rat model of allotransplantation (Guillonneau et al, JCI, 2007 ; Bezieetal, JCI, 2015). Here, we aim to characterize human CD8+ Tregs to assess their potential for cell therapy in transplantation in comparison to CD4+CD25[high]CD127- Tregs .
Fichier principal
Vignette du fichier
poster FOCIS 2017 final (1) (1).pdf (1.59 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-02159985 , version 1 (19-06-2019)

Identifiants

  • HAL Id : inserm-02159985 , version 1

Citer

Séverine Bézie, Dimitri Meistermann, Laetitia Boucault, Stephanie Kilens, Johanna Zoppi, et al.. Expanded human CD8+CD45RClowFoxp3+ Tregs secreting IFNγ, IL-10, IL-34 and TGFβinhibit human transplant rejection. FOCIS, Jun 2017, Chicago, United States. ⟨inserm-02159985⟩
38 Consultations
13 Téléchargements

Partager

Gmail Facebook X LinkedIn More